CPHI Japan 2027: a pharmaceutical supply-chain guide

CPHI Japan is a professional trade exhibition covering pharmaceutical ingredients, outsourcing, biopharmaceuticals, machinery and equipment, formulation and packaging. The 2027 edition is scheduled for 21–23 April 2027 at East Halls, Tokyo Big Sight, Tokyo, Japan. Its five zones are designed around connected parts of the pharmaceutical value chain, giving visitors and exhibitors a shared setting to examine products, services and manufacturing capabilities.

The organiser lists in-person opening hours of 10:00–17:00 each day. Visitor registration is not yet live: the current official form collects interest and says registrants will be notified when registration opens.

Why Tokyo CPHI Japan matters to pharmaceutical professionals

Compare connected supply-chain categories

Ingredients, outsourcing, biopharma, machinery and equipment, and formulation and packaging are represented as distinct event zones. For a buyer, this creates a practical way to consider an ingredient or service alongside the manufacturing and packaging capabilities needed to bring a product through its supply chain.

Use supplier conversations to clarify fit

Before shortlisting a supplier, compare the scope of its products or services, technical documentation, quality systems, capacity and the markets it supports. A stand conversation can help identify what needs a deeper technical or regulatory review; it is not a substitute for qualification or due diligence.

Understand the event's reported scale

For the 2026 edition, the organiser reported more than 18,000 pharmaceutical professionals on the show floor. This is a previous-edition figure, not a forecast for 2027. The organiser has not provided a comparable exhibitor total in the pages reviewed.

Who should visit Tokyo CPHI Japan?

Pharmaceutical buyers and procurement teams

Useful if you are evaluating suppliers, inputs or external services. Prioritise the categories that match your purchasing brief and compare:

• Product or service scope and intended application
• Quality documentation and relevant standards
• Available capacity, technical support and service boundaries
• Lead-time, supply-continuity and qualification questions
• Next steps for requesting specifications or a formal quotation

The organiser presents CPHI Japan as a place for buyers to source suppliers across its five pharmaceutical zones.

Manufacturers, ingredient companies and service providers

Useful if you are looking for partners, customers or service capabilities across the pharmaceutical supply chain. Prepare a concise explanation of your product range, target applications, quality credentials and the type of relationship you want to explore. Distinguish clearly between what you manufacture directly and what you provide through partners.

Technical, operations and business-development teams

Useful if you assess manufacturing equipment, outsourcing, biopharma or packaging options. Bring the process or development questions that matter to your organisation, and record the evidence needed for a technical review. CPHI's official description names manufacturers, innovators, buyers, senior executives and regulators among the people visitors can engage with.

What can you find at Tokyo CPHI Japan?

Pharma ingredients

Use the Ingredients Zone to explore suppliers and products within the ingredient category. For each relevant conversation, note the material, grade or application under discussion and request the product documentation your technical and quality teams require.

Outsourcing and contract services

The Outsourcing Zone is relevant to teams considering external development or manufacturing support. Clarify which stages a provider covers, what capabilities are performed in-house, what quality responsibilities apply and what information is needed for a feasibility discussion.

Biopharma

The Biopharma Zone brings this segment into the event's wider pharmaceutical supply-chain view. Technical and business teams can compare stated capabilities and identify questions for a later assessment of process fit, scale, quality and partnership structure.

Machinery and equipment

The Machinery & Equipment Zone is relevant to production, engineering and operations teams comparing equipment or manufacturing technologies. Define the process problem first; then ask about throughput, integration, validation, service and the evidence needed to assess performance.

Formulation, packaging and drug delivery

Official event pages identify formulation and packaging, and the visitor page also names a DDS & Packaging Zone. Packaging, formulation and delivery-system discussions can be more useful when you bring product requirements, compatibility questions and any relevant technical constraints.

What makes Tokyo CPHI Japan distinctive?

Its organising principle is the pharmaceutical supply chain, divided into five specialist zones. The official site lists Ingredients, Outsourcing, Biopharma, Machinery & Equipment, and Formulation & Packaging; its visitor page also describes DDS & Packaging. This cross-category structure can help visitors notice dependencies between materials, services, production technologies and finished-product presentation. The 2026 edition's reported attendance of more than 18,000 professionals indicates substantial prior-edition scale, while the next edition's own attendance and exhibitor figures should not be assumed in advance.

What should you try to achieve at Tokyo CPHI Japan?

If you are sourcing products or services

Leave with a qualified shortlist of suppliers that meet your stated technical and quality criteria. Record the product or service scope, evidence still required, contact person and agreed follow-up for each candidate.

If you are evaluating manufacturing or outsourcing

Identify which capabilities merit a formal feasibility or qualification review. Separate confirmed service scope from questions that need written answers, site assessment or internal approval.

If you are exhibiting or developing partnerships

Identify the relevant counterparties and the next information each would need. A useful outcome is a clearly defined follow-up, not simply a large collection of contacts.

How to prepare before Tokyo CPHI Japan

1. Set a purpose

Choose whether your priority is ingredient sourcing, an outsourcing partner, biopharma capability, equipment, formulation, packaging or market intelligence. Turn that purpose into a short list of questions and decision criteria.

2. Check registration status

The current event page offers a register-your-interest form and says visitors will be contacted when registration is live. Check the organiser's website for the registration process and any updated visitor requirements before making arrangements.

3. Build a target list

Use the organiser's exhibitor information when it becomes available. Group targets by zone and classify them as must-meet, useful or explore-if-time-allows. The current website shows 2026 exhibitors, so confirm that any company you wish to meet is participating in 2027 before planning around it.

4. Prepare technical and commercial questions

• Which products, services or process stages are included?
• What specifications, quality documents or validation evidence can be shared?
• What capacity, scale or operating conditions can the supplier support?
• Which activities are performed directly and which are outsourced?
• What qualification, sample or feasibility steps would follow?
• What local regulatory or market-access questions require specialist confirmation?
• What information does the supplier need to assess fit?
• Who owns the next action, and by when should you follow up?

How to make the most of the exhibition

Use a consistent record for every useful conversation: Company → product or service → why it may fit → evidence required → contact → next action. This helps distinguish a promising initial discussion from a solution that has passed technical, quality and commercial review.

Move between the five zones according to your objectives rather than trying to cover every display. For a sourcing brief, compare like with like first; then use adjacent categories to identify dependencies, such as how an ingredient, outsourced process, equipment choice or packaging requirement affects the overall decision.

Networking at Tokyo CPHI Japan

Prepare a short introduction that states your role, the products or capabilities you are assessing and the kind of partner you seek. If you are a buyer, describe the application and the information needed for supplier evaluation without sharing confidential specifications prematurely. If you are a supplier, ask about the prospect's decision process and agree what non-confidential material would be useful next.

After a conversation, write down the context while it is fresh and confirm permission before sending technical or commercial material. Keep confidential information within your organisation's approved channels.

One day or several days at Tokyo CPHI Japan?

The exhibition runs for three days, with official hours listed as 10:00–17:00. A focused one-day visit may suit a visitor with a short target list concentrated in one or two zones. More time may be useful if you need to compare suppliers across several categories, hold multiple technical discussions or return to shortlisted stands. Choose the duration from your meeting plan and confirm the final schedule with the organiser.

After Tokyo CPHI Japan: turn conversations into decisions

Within your organisation's normal follow-up window, sort contacts into three groups: A — immediate evaluation for candidates meeting core requirements; B — potential for contacts needing more information; and C — market intelligence for conversations that help clarify the wider supplier landscape.

For each A or B contact, send a concise recap and request only the next evidence needed: specifications, quality documents, service scope, capacity information, sample availability or a technical meeting. Compare suppliers against the same criteria and involve quality, regulatory, technical and procurement colleagues as appropriate.

Who should consider exhibiting at Tokyo CPHI Japan?

The organiser's zones are intended for companies working in pharmaceutical ingredients, outsourcing, biopharma, machinery and equipment, formulation, packaging and drug delivery. Exhibiting may be relevant to manufacturers, service providers and technology suppliers whose capabilities fit these categories and the audiences they serve.

Before committing, define the objective: explain a new capability, meet a particular type of partner, test market interest or support existing relationships. Check the organiser's current exhibitor prospectus for stand options, costs, deadlines and participation terms; those details are not stated here.

Tokyo CPHI Japan visitor checklist

Before

• ☐ Choose priority zones and decision questions.
• ☐ Check when visitor registration opens and confirm 2027 exhibitor information.
• ☐ Prepare technical and quality questions and a contact-record template.
• ☐ Confirm travel and entry requirements for your circumstances.

During

• ☐ Capture the product or service scope and evidence still needed.
• ☐ Record a named contact and a specific next action.
• ☐ Separate verified capability from claims that need follow-up.

After

• ☐ Prioritise supplier follow-up and involve the right internal reviewers.
• ☐ Compare candidates against the same requirements.
• ☐ Keep market observations separate from purchasing decisions.

Is Tokyo CPHI Japan worth visiting?

It is most relevant to pharmaceutical professionals whose work connects with ingredients, outsourced services, biopharma, manufacturing equipment, formulation, packaging or drug delivery. Buyers can use its specialist zones to structure supplier comparisons; manufacturers and service providers can investigate partnership fit; technical teams can clarify which capabilities merit deeper review. The value of the visit depends on bringing clear criteria and following up systematically. A walk through the halls without defined priorities is less likely to answer the questions that matter to your organisation.

Tokyo CPHI Japan 2027 at a glance

The organiser confirms the 2027 dates, venue and daily hours; the 18,000-plus attendance figure relates to 2026.

Plan your Tokyo CPHI Japan visit with a clear outcome

Before you go, ask: Which supplier, capability or market question do I need to resolve? Use the zones to compare relevant options, document what still needs verification and follow up with a defined next step. Compare. Clarify. Evaluate. Follow up.

Pharmaceutical opportunities in Japan

Market size and demand

JETRO's life-sciences market page reports a Japanese domestic pharmaceutical market of about JPY 11.65 trillion in FY2021 and drug imports of about JPY 3.04 trillion in FY2021, based on MHLW pharmaceutical-industry production statistics. These are historical benchmarks, not current market estimates; they indicate the scale of the market and the presence of imported medicines, but do not by themselves establish demand for a specific product or supplier.

Market drivers and commercial opportunities

JETRO describes biopharmaceuticals and contract manufacturing/development services as areas of interest in Japan's pharmaceutical sector. This may make it worthwhile for qualified biopharma, CMO or CDMO companies to investigate local partnerships and capability requirements. The event's outsourcing and biopharma zones provide a relevant setting for initial supplier and partner discussions, but commercial fit and demand must be assessed product by product.

Regulations and market-entry conditions

Japan's product approval and marketing procedures depend on product classification. PMDA advises companies to confirm product-specific requirements with a designated Marketing Authorization Holder in Japan. Foreign suppliers should establish the applicable pathway and local responsibilities with qualified regulatory support before treating an exhibition conversation as evidence of market readiness.

What this may mean for exhibitors

Manufacturers and service providers may use the event to identify potential local counterparties and clarify what technical, quality and regulatory information a market-entry discussion would require. The historical data and event presence are not guarantees of a customer, partner or commercial return.

What this may mean for visitors

Buyers and technical teams may compare international suppliers and external capabilities, then assess them against their own product requirements, qualification process and Japan-specific regulatory obligations. Ask suppliers to distinguish established local arrangements from plans that still require confirmation.

Discover Tokyo

Tokyo pairs a major international business setting with historic religious sites and carefully maintained urban gardens. Tokyo Big Sight is in Ariake, within Tokyo's Koto ward, so the venue is in the host city itself.

Sensoji Temple and Nakamise-dori

The Asakusa temple complex is approached through Kaminarimon Gate and the historic Nakamise-dori shopping street, offering a distinctive historic district to explore outside exhibition hours.

Hamarikyu Gardens

This historic Tokyo garden preserves links to Edo-period uses, including cultivation and falconry, and offers a quieter contrast to the city's contemporary commercial districts.

Visitors can fit a city visit around their business schedule, checking current opening and access details directly before setting plans.